Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$2,000,000.00Target Investment:
$1,000,000.00
Skills
Lists including Stephen
Investments
Tastee Tape
Total Funding:
BugBiome
Total Funding:
Xias Bio
Total Funding:
Helex
Total Funding: $1M
Calder Biosciences
Total Funding: $630K
Cell BioEngines
Total Funding: $1M
CroBio
Total Funding: $2.5M
Athos Bioindustries
Total Funding:
Cayuga Biotech
Total Funding: $250K
BioLattice
Total Funding:
Work Experience
2020
Managing Director at IndieBio NY & General Partner at SOSV
2020
2019 - 2021
Royal Society Entrepreneur in Residence
2019 - 2021
Helping commercialise world-leading research and address skills gaps in the emerging synthetic biology industry using real-world experience to help foster an entrepreneurial culture within universities and develop curricula to produce industry-ready graduates.
2016 - 2018
Co Founder
2016 - 2018
Accelerator for early stage companies looking to make an impact by solving the worlds most pressing problems. Biostart aims to support high-impact businesses targeting substantial markets with disruptive technology. Companies or teams with first class commercial acumen operating in any industry sector may apply. No age limits for the team or the company but any company applying must not have raised more than £500k equity funding. Annual competition is designed to commercialise the engineering of biology. The prize is £200k package (£100k equity free cash prize, six months free laboratory space, £25k consumables, £15k professional services). Non-dilutive, no equity taken. All entrants past the initial stage receive substantial mentoring and exposure to VC and business networks with a grand final event providing PR and networking opportunities.
2014 - 2018
CEO
2014 - 2018
Innovation and Knowledge Centre for Synthetic Biology, with the mission to accelerate and promote the commercial exploitation of synthetic biology research and technology in the UK. Author of the UK Synthetic Biology Start-up Survey.
2014 - 2018
Advisory Board Member
2014 - 2018
The establishment of the London DNA Foundry at Imperial College heralds a new chapter in the development of synthetic biology to meet new global challenges. The Foundry employs the latest technology to make the process of engineering biology easier, faster and scalable. The integration of advanced software, automation and analytics allows the rapid design, build and testing of engineered organisms.
2008 - 2013
Co Founder
2008 - 2013
Co-founded company producing novel antibodies & proteins for biomedical research.
1990 - 2007
Director of Gene Expression
1990 - 2007
A founding scientist and Director of Gene Expression at Vertex